Efficacy News and Research

RSS

Researchers devise strategy to target Achilles heel of nervous system cancers

Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment.

21 Jul 2017

FDA clears first MRI device for neonatal brain and head imaging

Today, the U.S. Food and Drug Administration cleared the first magnetic resonance imaging device specifically for neonatal brain and head imaging in neonatal intensive care units.

20 Jul 2017

Study: Response to combination immunotherapy in melanoma depends on proportion of immune cells

Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco researchers joined by physicians from UCSF Health.

20 Jul 2017

These preventive measures might help delay dementia or cognitive decline

In a landmark report, scientists have endorsed three strategies for preventing dementia and cognitive decline associated with normal aging — being physically active, engaging in cognitive training and controlling high blood pressure.

20 Jul 2017

Doctors appear to have reached unexpected consensus in prescribing pediatric anti-seizure medications

The number of available anti-seizure medications has exploded in the past two decades, going from just a handful of medicines available in the 1990s to more than 20 now.

19 Jul 2017

Skin-applied microneedle patch boosts immunization to seasonal flu vaccine recipients, study finds

A boosting skin vaccination with a biodegradable microneedle patch and protein constructed from sequences of influenza virus subtypes could improve the effectiveness of conventional influenza vaccines, according to a study led by Georgia State University.

19 Jul 2017

New study shows how social interaction impacts treatment response in cancer patients

How well cancer patients fared after chemotherapy was affected by their social interaction with other patients during treatment, according to a new study by researchers at the National Human Genome Research Institute, part of the National Institutes of Health, and the University of Oxford in the United Kingdom.

19 Jul 2017

FDA approves fixed-dose combination tablet for treating adults with chronic hepatitis C

The U.S. Food and Drug Administration today approved Vosevi to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis.

18 Jul 2017

Developing software for cell and gene therapy supply chain tracking

The first thing is, to always remember that we're dealing with a living drug, cells, which are very sensitive to environmental conditions, such as temperature and humidity etc. All of those things can impact on the viability of the drug and its effectiveness.

18 Jul 2017

FDA approves first extended adjuvant therapy to lower risk of breast cancer recurrence

The U.S. Food and Drug Administration today approved Nerlynx (neratinib) for the extended adjuvant treatment of early-stage, HER2-positive breast cancer.

18 Jul 2017

Clear recommendations can be given only for few stutter therapies, say experts

About 1% of children and adolescents, 0.2% of women, and 0.8% of men suffer from stuttering. However, based on the available studies, clear recommendations can be given only for a few of the currently available stutter therapies.

14 Jul 2017

MGH researchers identify novel mechanism behind resistance to angiogenesis inhibitors

A Massachusetts General Hospital research team has identified a novel mechanism behind resistance to angiogenesis inhibitors - drugs that fight cancer by suppressing the formation of new blood vessels.

14 Jul 2017

LSTM awarded £11 million by NIHR to establish new research unit and groups

LSTM has been awarded £11 million by the National Institute for Health Research as part of their latest UK-wide call for funding into Global Health Research Units.

14 Jul 2017

BASF unveils breakthrough insecticide for malaria control

BASF has received a recommendation from the World Health Organization for Interceptor(R) G2, a long-lasting insecticide-treated mosquito net (LN) based on chlorfenapyr.

13 Jul 2017

Many parents have limited understanding of concussions, study finds

Despite the large volume of information about sports-related concussions on the Internet, many parents and guardians of young athletes have a limited understanding of concussions, according to a study co-authored by a faculty member of UTA's College of Nursing and Health Innovation.

13 Jul 2017

Ground-breaking new breast cancer drugs have manageable toxicity profile for most patients

A ground-breaking new class of oral drugs for treating breast cancer, known as cyclin-dependent kinase (CDK) inhibitors, are generally well-tolerated, with a manageable toxicity profile for most patients.

13 Jul 2017

Study assesses success and efficacy of ovarian tissue freezing

Many women are turning to egg freezing to promote fertility, but what happens when it isn't an option because of special medical or other conditions? And, what option is there for women who want to preserve hormonal function, not just fertility?

13 Jul 2017

Cord-blood-derived natural killer cells can be modified to destroy B-cell cancers

Immune cells with a general knack for recognizing and killing many types of infected or abnormal cells also can be engineered to hunt down cells with specific targets on them to treat cancer, researchers at The University of Texas MD Anderson Cancer Center report in the journal Leukemia.

13 Jul 2017

Computational analysis of open-access data points to new ways of using drugs

A research team led by scientists at UC San Francisco has developed a computational method to systematically probe massive amounts of open-access data to discover new ways to use drugs, including some that have already been approved for other uses.

12 Jul 2017

Gelesis reports completion of treatment for last patient in pivotal GLOW study

Gelesis, Inc., a biotechnology company developing a novel category of therapies to safely induce weight loss, improve glycemic control, and treat other chronic diseases related to the gastrointestinal (GI) pathway, is pleased to report today that the last patient has completed treatment in the pivotal GLOW (Gelesis Loss Of Weight) Study.

12 Jul 2017

Efficacy News and Research

Researchers devise strategy to target Achilles heel of nervous system cancers

FDA clears first MRI device for neonatal brain and head imaging

Study: Response to combination immunotherapy in melanoma depends on proportion of immune cells

These preventive measures might help delay dementia or cognitive decline

Doctors appear to have reached unexpected consensus in prescribing pediatric anti-seizure medications

Skin-applied microneedle patch boosts immunization to seasonal flu vaccine recipients, study finds

New study shows how social interaction impacts treatment response in cancer patients

FDA approves fixed-dose combination tablet for treating adults with chronic hepatitis C

Developing software for cell and gene therapy supply chain tracking

FDA approves first extended adjuvant therapy to lower risk of breast cancer recurrence

Clear recommendations can be given only for few stutter therapies, say experts

MGH researchers identify novel mechanism behind resistance to angiogenesis inhibitors

LSTM awarded £11 million by NIHR to establish new research unit and groups

BASF unveils breakthrough insecticide for malaria control

Many parents have limited understanding of concussions, study finds

Ground-breaking new breast cancer drugs have manageable toxicity profile for most patients

Study assesses success and efficacy of ovarian tissue freezing

Cord-blood-derived natural killer cells can be modified to destroy B-cell cancers

Computational analysis of open-access data points to new ways of using drugs

Gelesis reports completion of treatment for last patient in pivotal GLOW study

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News